Abstract
We report a label-free, gold nanoparticles (AuNPs)-based chemiluminescent method for propranolol assay. The method relies upon the catalytic activity of unmodified AuNPs on the luminol–H2O2 chemiluminescence (CL) reaction, and the interaction of unmodified AuNPs with propranolol. The surface charge property of AuNPs directly affects their catalytic performance for CL reaction, and the interaction of AuNPs with propranolol can change AuNPs׳ surface charge property and induce the AuNP aggregation, and after aggregation the catalytic activity of AuNPs on the luminol–H2O2 CL reaction is greatly enhanced. During the assay, no covalent functionalization of AuNPs is required. The assay is homogenous. The detection limit of propranolol (3σ) was estimated to be as low as 6.6×10−12gmL−1, and the sensitivity was 4 orders of magnitude better than that of known CL methods for the detection of propranolol. This AuNPs-based CL method offers the advantages of being simple, cheap, rapid, and sensitive.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
